Bookmark

Add to MyYahoo RSS

Hemophilia News

News on Hemophilia continually updated from thousands of sources around the net.

17 hrs ago | P&T Community

Positive Phase III Results Reported for BAX 855 in Treatment of Hemophilia A

Positive results have been reported from a phase III pivotal trial of BAX 855 , an investigational, extended half-life recombinant factor VIII treatment for hemophilia A based on Advate .

Comment?

Related Topix: Health, Healthcare Law, Law

Yesterday | Sussex Sun

Nikolai Strikes Back

GREAT LAKES HEMOPHILIA FOUNDATION FUNDRAISER My great-grandson, Nikolai Jopek, was born with severe type 3 Hemophilia on July 26, 2012.

Comment?

Related Topix: Health, Milwaukee County, WI, Milwaukee, WI, Family, Kids

Thu Aug 21, 2014

Hispanic Business

Baxter Announces Positive Top-Line Results from Its Phase 3 Study of...

Top-line results from the prospective, global, multi-center Phase 3 study demonstrated that BAX 855 met its primary endpoint in the control and prevention of bleeding, routine prophylaxis and perioperative management for patients who were 12 years or older.

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry, Healthcare Law, Law, Health, Antihemophilic Factor (generic), Kogenate, Antihemophilic Factor (generic)

BioSpace

Long-Acting Version Of Baxter International, Inc.'s Hemophilia A Drug BAX 855 Succeeds In Study

Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients * Twice-Weekly Prophylactic Regimen Resulted in 95% Reduction in Median Annualized Bleed Rate Compared to On-Demand * Company Initiating Phase 3 Study of BAX 855 in Pediatric Hemophilia A Patients DEERFIELD, ... (more)

Comment?

Related Topix: Health, Medicine, Baxter International, Medical Equipment, Healthcare Industry, E.Factor, World News, Algeria, Kogenate, Antihemophilic Factor (generic)

Reuters

Long-acting version of Baxter's hemophilia drug succeeds in study

Baxter International Inc said a more potent version of its flagship blood disorder drug Advate met the main goal in a late-stage study.

Comment?

Related Topix: Health, Medicine, Baxter International, Medical Equipment, Healthcare Industry, Genetics, Healthcare Law, Law

Seeking Alpha

Baxter hemophilia drug successful in Phase 3 trial

In a 138-patient Phase 3 clinical trial evaluating the safety and efficacy of Baxter International's BAX 855 , an extended half-life recombinant factor VIII for the treatment of hemophilia A, the product candidate met its primary endpoint of reducing annualized bleed rates in the prophylaxis arm versus the on-demand arm.

Comment?

Related Topix: Health, Medical Equipment, Medicine, Baxter International, Healthcare Industry

Tue Aug 19, 2014

MedicineNet

AIDS Retrospective Pictures Slideshow: A Pictorial Timeline of the HIV/AIDS Pandemic

The first cases of AIDS were reported in 1981, and since then, more than 25 million people worldwide have died from the illness.

Comment?

Related Topix: HIV/AIDS, Health, Epidemic, Natural Disasters, Centers for Disease Control and Prevention, Control Group, Sarcoma, Medicine

Mon Aug 18, 2014

Post-gazette.com

Foundation reviews triumphs, challenges of AIDS fight

In the future, researchers could develop an injection to prevent HIV/a AIDS, and those who have the disease could become so adept at managing it that they might have to visit their doctors only once a year.

Comment?

Related Topix: Medicine, Health, Pittsburgh, PA, University of Pittsburgh

Circulation

Cerebral and Sinus Vein Thrombosis [Cardiology Patient Page]

From the Department of Medicine, Division of Hematology-Oncology, University of North Carolina School of Medicine , and the Hemophilia and Thrombosis Center, University of North Carolina , Chapel Hill, NC.

Comment?

Related Topix: Oncology, Medicine, Hematology, Health, Chapel Hill, NC

Hispanic Business

Expression Therapeutics LLC Selects ABL, Inc. to Support Cell Line...

Expression Therapeutics' recombinant factor VIII platform generates 100-fold greater expression than current products.

Comment?

Related Topix: Health

Sat Aug 16, 2014

Weekend Balita

Senator pushes accessible aid for Filipinos with 'Royal Disease'

Philippine Senator Grace Poe flanked by Kalayaan 2014 Asst. Secretary Mary Ann Omega and President Emeritus of the Filipino-American Chamber of Commerce of Los Angeles and past Kalayaan Chair and Chairman of the National Federation of Filipino American Associations Noel S. V. Omega during the senator's arrival at Los Angeles International Airport .

Comment?

Related Topix: Health

Fri Aug 15, 2014

Seeking Alpha

Regado Biosciences' Revolixys Kit: Assessing The Risks Of Allergic Reactions

Regado Biosciences is currently involved in a phase III clinical trial for Revolixys Kit, its system for precisely controlling blood clotting.

Comment?

Related Topix: Healthcare Law, Law, Regado Biosciences, Health, Supplement, RNA

Wed Aug 13, 2014

Hispanic Business

Alnylam Pharmaceuticals Posts Second Quarter Results

The non-GAAP net loss for the second quarter of 2014 excludes the reduction to in-process research and development expense related to the purchase of the Sirna RNAi assets from Merck.

Comment?

Related Topix: Biotech, Alnylam Pharmaceuticals, Sirna Therapeutics, Healthcare Industry, Health

The Motley Fool

3 Reasons Baxter International Inc.'s Stock Could Rise

You're about to live through that well-known saying, "Crisis equals opportunity."

Comment?

Related Topix: Medicine, Baxter International, Medical Equipment, Healthcare Industry, Health

Tue Aug 12, 2014

Molecular Therapy

Hyperactive PiggyBac Transposons for Sustained and Robust Liver-targeted Gene Therapy

Correspondence: Thierry VandenDriessche, Department of Gene Therapy and Regenerative Medicine, Free University of Brussels, Laarbeeklaan, Brussels, Belgium.

Comment?

Related Topix: World News, Belgium, Health

Seeking Alpha

Baxter International: A Spin-Off Play And An Increasing Dividend

Baxter International is a company that is entering an exciting period. After acquiring some businesses and divesting others over recent years, the company has decided to split into two separate companies.

Comment?

Related Topix: Medicine, Baxter International, E.Factor, Medical Equipment, Healthcare Industry, Financial Markets, Health

Mon Aug 11, 2014

Freshnews

OPKO Announces Second Quarter Operating and Financial Results

OPKO Health, Inc. , a multi-national biopharmaceutical and diagnostics company, today reported operating and financial results for its second quarter ended June 30, 2014.

Comment?

Related Topix: Biotech, Opko Health, Food and Drug Administration, Health, Medicine, Urology, Prostate Cancer

Medical Device/Diagnostic Ind.

Which Medtech Companies Hired the Most People in 2013?

Baxter International with headquarters in Deerfield, Illinois, makes products that treat hemophilia, kidney disease, immune disorders and other chronic diseases and conditions.

Comment?

Related Topix: Medicine, Baxter International, E.Factor, Medical Equipment, Healthcare Industry, Deerfield, IL, Health

Biopharm

Baxter Opens Its First Biologics Facility in Asia

Baxter International Inc. announced the formal opening of its first advanced recombinant biologic facility in Singapore and expansion plans for a new recombinant protein-processing suite.

Comment?

Related Topix: Medical Equipment, Medicine, Baxter International, Healthcare Industry, Health

Fri Aug 08, 2014

PeoriaTimes-Observer

Dr. Jeff Hersh: What causes monoarticular arthritis?

Q: My left knee started to swell up and hurt, and my doctor said it was some kind of arthritis and he gave me an antibiotic.

Comment?

Related Topix: Medicine, Arthritis, Health, Gout

•••
•••
•••
•••
•••
•••
•••
•••